What to do at step 3 of the asthma guidelines—increase the dose of inhaled corticosteroids or add a long-acting β-agonist drug?

CG Lofdahl, S Larsson, L Wahlander, P Arvidsson, B Melander, N Svedmyr, Inhaled formoterol during one year in asthma: a comparison with salbutamol European Respiratory Journal. ,vol. 4, pp. 1168- 1173 ,(1991)

ANNIKA WALLIN, THOMAS SANDSTRÖM, MARGARETHA SÖDERBERG, PETER HOWARTH, BO LUNDBÄCK, GIOVANNI DELLA-CIOPPA, SUSAN WILSON, MARY JUDD, RATKO DJUKANOVIĆ, STEPHEN HOLGATE, ANNE LINDBERG, LARS LARSSEN, Mary Judd, Bo Melander, The Effects of Regular Inhaled Formoterol, Budesonide, and Placebo on Mucosal Inflammation and Clinical Indices in Mild Asthma American Journal of Respiratory and Critical Care Medicine. ,vol. 159, pp. 79- 86 ,(1999) , 10.1164/AJRCCM.159.1.9801007

XUN LI, CHRIS WARD, FRANCIS THIEN, ROS BISH, TIFFANY BAMFORD, XIANGHUA BAO, MICHAEL BAILEY, JOHN W. WILSON, E. HAYDN WALTERS, An Antiinflammatory Effect of Salmeterol, a Long-acting β2 Agonist, Assessed in Airway Biopsies and Bronchoalveolar Lavage in Asthma American Journal of Respiratory and Critical Care Medicine. ,vol. 160, pp. 1493- 1499 ,(1999) , 10.1164/AJRCCM.160.5.9811052

JOHAN C. KIPS, BRIAN J. O'CONNOR, MARK D. INMAN, KLAS SVENSSON, ROMAIN A. PAUWELS, PAUL M. O'BYRNE, A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. American Journal of Respiratory and Critical Care Medicine. ,vol. 161, pp. 996- 1001 ,(2000) , 10.1164/AJRCCM.161.3.9812056

Stephen Shrewsbury, Stephen Pyke, Mark Britton, Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA) BMJ. ,vol. 320, pp. 1368- 1373 ,(2000) , 10.1136/BMJ.320.7246.1368

John J. Condemi, Stanley Goldstein, Christopher Kalberg, Steven Yancey, Amanda Emmett, Kathleen Rickard, The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma Annals of Allergy Asthma & Immunology. ,vol. 82, pp. 383- 389 ,(1999) , 10.1016/S1081-1206(10)63288-7

S. Holt, A. Suder, M. Weatherall, S. Cheng, P. Shirtcliffe, R. Beasley, A. Herxheimer, Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ. ,vol. 323, pp. 253- 256 ,(2001) , 10.1136/BMJ.323.7307.253

Annika Wallin, Malcolm Sue-Chu, Leif Bjermer, Jonathan Ward, Thomas Sandström, Anne Lindberg, Bo Lundbäck, Ratko Djukanovic ́, Stephen Holgate, Susan Wilson, Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma Journal of Allergy and Clinical Immunology. ,vol. 112, pp. 72- 78 ,(2003) , 10.1067/MAI.2003.1518

D. Bouros, N. Bachlitzanakis, J Kottakis, P Pfister, V Polychronopoulos, E Papadakis, S Constantopoulos, M. Froudarakis, L Sichletidis, N. Siafakas, Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma European Respiratory Journal. ,vol. 14, pp. 627- 632 ,(1999) , 10.1034/J.1399-3003.1999.14C24.X

A.P Greening, P.W Ind, M Northfield, G Shaw, Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid The Lancet. ,vol. 344, pp. 219- 224 ,(1994) , 10.1016/S0140-6736(94)92996-3